Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Melanoma 1Cervical Cancer Screening 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vaccination × 1 year × Clear all
NCT04335890 2026-03-04

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Hasumi International Research Foundation

Phase 1 Completed
17 enrolled
Dermatologic

Melanoma

NCT07113379 2025-08-08

REVIVE

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting
200 enrolled
Gynecologic

Cervical Cancer Screening

Data powered by HemOnc (CC BY 4.0) Colophon âš¡